<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04498000</url>
  </required_header>
  <id_info>
    <org_study_id>R1661/58/2019</org_study_id>
    <nct_id>NCT04498000</nct_id>
  </id_info>
  <brief_title>Analysis of the Pachychoroid Phenotype in an Asian Population</brief_title>
  <official_title>Analysis of the Pachychoroid Phenotype in an Asian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore National Eye Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Singapore National Eye Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The understanding of pachychoroid phenotype is incomplete. It is important to understand the&#xD;
      risk of conversion from an uncomplicated pachychoroid phenotype to the pachychoroid disease&#xD;
      phenotype, to guide appropriate management of these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The progression of uncomplicated pachychoroid phenotype to pachychoroid disease is not well&#xD;
      established and the pathophysiology of these phenotypes remains unknown: specifically if the&#xD;
      occurence of pachyvessels is the primary event, or develops secondary to the inner choroidal&#xD;
      attenuation.&#xD;
&#xD;
      A longitudinal study of the pachychoroid phenotype will provide much needed information&#xD;
      regarding the natural history of the pachychoroid phenotype. Secondly, a detailed chronicle&#xD;
      of the choroidal alterations in the pachychoroid disease spectrum may yield insights into the&#xD;
      pathogenesis, and facilitate the development of disease modulation strategies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of progression of pachychoroid phenotypes in 2 subtypes</measure>
    <time_frame>2 years observation</time_frame>
    <description>Two subtypes of pachychoroid phenotypes:&#xD;
from an uncomplicated pachychoroid phenotype, to a pachychoroid disease entity&#xD;
from non neo-vascular pachychoroid disease, to neovascular pachychoroid disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for progression in 2 subtypes of pachychoroid phenotypes</measure>
    <time_frame>2 years</time_frame>
    <description>from an uncomplicated pachychoroid phenotype, to a pachychoroidal disease entity&#xD;
from neo-vascular pachychoroid disease, to neovascular pachychoroid disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess the chronology of choroidal changes in patients</measure>
    <time_frame>2 years</time_frame>
    <description>Determine the occurence of pachyvessles is the primary event, or consequent to inner choroidal attenuation</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pachychoroid Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will recruit 120 participants from the Singapore National Eye Centre (SNEC) and&#xD;
        National University Hospital (NUH). SNEC will recruit 70 participants and NUH will recruit&#xD;
        50 participants for this study. There is no subject restriction based on race of the&#xD;
        subject.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Presence of uncomplicated and/or non-neovascular pachychoroid phenotype in at least&#xD;
             one eye.&#xD;
&#xD;
          2. Subfoveal choroidal thickness &gt;300 microns on enhanced depth imaging optical coherence&#xD;
             tomography for at least one eye&#xD;
&#xD;
          3. Male or female patients above 45 years of age&#xD;
&#xD;
          4. Willingness to undergo pupil dilation, and protocol- required procedures for both eyes&#xD;
&#xD;
          5. Willing to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of disorders of the ocular media which interfere with visual acuity and other&#xD;
             ocular assessments, including Spectral domain- optical coherence tomography during the&#xD;
             study period&#xD;
&#xD;
          2. Pregnant or nursing women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinyi Su, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gemmy Cheung, MBBS</last_name>
    <phone>+65 83828173</phone>
    <email>gemmy.cheung.c.m@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelvin Teo, MBBS</last_name>
    <phone>+65 98000002</phone>
    <email>kelvin.teo.y.c@singhealth.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinyi Su, MBBS</last_name>
      <email>xinyi_su@nuhs.edu.sg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Singapore National Eye Centre</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Singapore National Eye Centre</investigator_affiliation>
    <investigator_full_name>Gemmy Cheung Chui Ming</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>pachychoroid neovasculopathy</keyword>
  <keyword>pachychoroid choroidal vasculopathy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

